Management of Acute and Recurrent Pericarditis: JACC State-of-the-Art Review.

[1]  C. Jellis,et al.  Imaging-Guided Therapies for Pericardial Diseases. , 2019, JACC. Cardiovascular imaging.

[2]  J. Bogaert,et al.  Usefulness of Cardiac Magnetic Resonance for Recurrent Pericarditis. , 2019, The American journal of cardiology.

[3]  A. Sambola,et al.  Colchicina administrada en el primer episodio de pericarditis aguda idiopática: estudio multicéntrico abierto y aleatorizado , 2019, Revista Española de Cardiología.

[4]  M. Senni,et al.  Constrictive pericarditis: a common physiopathology for different macroscopic anatomies. , 2019, Journal of cardiovascular medicine.

[5]  F. Ecarnot,et al.  Pericardiectomy for constrictive pericarditis: a risk factor analysis for early and late failure , 2019, Heart and Vessels.

[6]  P. Cacoub,et al.  Corticosteroids and immunosuppressive agents for idiopathic recurrent pericarditis. , 2019, Autoimmunity reviews.

[7]  Y. Shoenfeld,et al.  Anakinra in idiopathic recurrent pericarditis refractory to immunosuppressive therapy; a preliminary experience in seven patients. , 2019, Autoimmunity reviews.

[8]  R. Herbst,et al.  Immune Checkpoint Inhibitor-Associated Pericarditis. , 2019, Journal of Thoracic Oncology.

[9]  A. Klein,et al.  Multimodality Imaging for the Assessment of Pericardial Diseases , 2019, Current Cardiology Reports.

[10]  A. Klein,et al.  Pericardial diseases in patients with hypothyroidism , 2019, Heart.

[11]  R. Manka,et al.  Non-steroidal anti-inflammatory drug use in acute myopericarditis: 12-month clinical follow-up , 2019, Open Heart.

[12]  D. Phelan,et al.  Exercise Is Good for the Heart But Not for the Inflamed Pericardium? , 2019, JACC. Cardiovascular imaging.

[13]  A. Klein,et al.  RILONACEPT IN RECURRENT PERICARDITIS: FIRST EFFICACY AND SAFETY DATA FROM AN ONGOING PHASE 2 PILOT CLINICAL TRIAL , 2019, Journal of the American College of Cardiology.

[14]  F. Montecucco,et al.  Inflammation and pericarditis: Are neutrophils actors behind the scenes? , 2018, Journal of cellular physiology.

[15]  M. Ntsekhe,et al.  Epidemiology of pericardial diseases in Africa: a systematic scoping review , 2018, Heart.

[16]  R. Kornowski,et al.  Prodromal symptoms predict myocardial involvement in patients with acute idiopathic pericarditis. , 2018, International journal of cardiology.

[17]  A. Garin,et al.  Metropolitan W135 meningococcal compressive pericarditis treated with intrapericardial fibrinolysis , 2018, BMJ Case Reports.

[18]  M. Böhm,et al.  The first post-cardiac injury syndrome reported following transcatheter aortic valve implantation: a case report , 2018, European heart journal. Case reports.

[19]  G. Bertsias,et al.  Canakinumab for recurrent rheumatic disease associated-pericarditis: a case series with long-term follow-up. , 2018, Rheumatology.

[20]  Y. Adler,et al.  Recurrent pericarditis: still idiopathic? The pros and cons of a well-honoured term , 2018, Internal and Emergency Medicine.

[21]  Arjun K. Ghosh,et al.  Pericardial Disease in Cancer Patients , 2018, Current Treatment Options in Cardiovascular Medicine.

[22]  A. Abbate,et al.  The NLRP3 inflammasome in acute myocardial infarction , 2018, Nature Reviews Cardiology.

[23]  Sung‐A Chang.  Tuberculous and Infectious Pericarditis. , 2017, Cardiology clinics.

[24]  Amjad M Ahmed,et al.  Multimodality Imaging of Pericardial Diseases , 2017, Current Treatment Options in Cardiovascular Medicine.

[25]  R. Kornowski,et al.  Seasonal patterns of acute and recurrent idiopathic pericarditis , 2017, Clinical cardiology.

[26]  P. T. Ureta,et al.  Idiopathic relapsing acute pericarditis: Report of one case with favorable response to anakinra. , 2017, Medicina clinica.

[27]  C. Wiysonge,et al.  Interventions for treating tuberculous pericarditis , 2017, The Cochrane database of systematic reviews.

[28]  F. Gaita,et al.  Acute and Recurrent Pericarditis: Still Idiopathic? , 2017, Journal of the American College of Cardiology.

[29]  B. Tamarappoo,et al.  Quantitative Pericardial Delayed Hyperenhancement Informs Clinical Course in Recurrent Pericarditis. , 2017, JACC. Cardiovascular imaging.

[30]  A. Brucato,et al.  Is colchicine really harmful in viral myocarditis? , 2017, International journal of cardiology.

[31]  S. Hyun,et al.  [18F]Fluorodeoxyglucose PET/CT Predicts Response to Steroid Therapy in Constrictive Pericarditis. , 2017, Journal of the American College of Cardiology.

[32]  P. Herbst,et al.  Redefining Effusive-Constrictive Pericarditis with Echocardiography , 2016, Journal of cardiovascular ultrasound.

[33]  Arnav Kumar,et al.  Complicated Pericarditis: Understanding Risk Factors and Pathophysiology to Inform Imaging and Treatment. , 2016, Journal of the American College of Cardiology.

[34]  M. Sormani,et al.  Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial. , 2016, JAMA.

[35]  S. Heymans,et al.  Colchicine aggravates coxsackievirus B3 infection in mice. , 2016, International journal of cardiology.

[36]  H. Schaff,et al.  A 20-year experience with isolated pericardiectomy: Analysis of indications and outcomes. , 2016, The Journal of thoracic and cardiovascular surgery.

[37]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Circulation.

[38]  V. Kraus,et al.  Colchicine--Update on mechanisms of action and therapeutic uses. , 2015, Seminars in arthritis and rheumatism.

[39]  N. Al-Attar,et al.  2015 ESC Guidelines for the diagnosis and management of pericardial diseases , 2015, European heart journal.

[40]  F. Gaita,et al.  Evaluation and Treatment of Pericarditis: A Systematic Review. , 2015, JAMA.

[41]  S. Bressieux-Degueldre,et al.  A case of corticosteroid-dependent recurrent pericarditis with different response to two IL-1 blocking agents , 2015, Pediatric Rheumatology.

[42]  M. Carrier,et al.  Pericardiectomy for Constrictive Pericarditis: 20 Years of Experience at the Montreal Heart Institute. , 2015, The Annals of thoracic surgery.

[43]  D. Raoult,et al.  Etiology of Pericarditis in a Prospective Cohort of 1162 Cases. , 2015, The American journal of medicine.

[44]  M. Abraham,et al.  Propionibacterium acnes: A Treatable Cause of Constrictive Pericarditis , 2015, Case reports in medicine.

[45]  P. Cremer,et al.  Multimodality Imaging of Pericardial Disease , 2015, Current Cardiology Reports.

[46]  B. Griffin,et al.  Usefulness of cardiac magnetic resonance-guided management in patients with recurrent pericarditis. , 2015, The American journal of cardiology.

[47]  J. Coons,et al.  Pharmacotherapy Update of Acute Idiopathic Pericarditis , 2015, Pharmacotherapy.

[48]  S. Achenbach,et al.  European Association of Cardiovascular Imaging (EACVI) position paper: Multimodality imaging in pericardial disease. , 2014, European heart journal cardiovascular Imaging.

[49]  D. H. Spodick,et al.  Colchicine for pericarditis. , 2014, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[50]  P. Andersen,et al.  Relation of nonsteroidal anti-inflammatory drugs to serious bleeding and thromboembolism risk in patients with atrial fibrillation receiving antithrombotic therapy: a nationwide cohort study. , 2014, Annals of internal medicine.

[51]  Masafumi Takahashi,et al.  Letter by Takahashi regarding article "targeting interleukin-1 in heart disease". , 2014, Circulation.

[52]  Y. Adler,et al.  Efficacy and safety of colchicine for treatment of multiple recurrences of pericarditis (CORP-2): a multicentre, double-blind, placebo-controlled, randomised trial , 2014, The Lancet.

[53]  H. Wiste,et al.  Echocardiographic Diagnosis of Constrictive Pericarditis: Mayo Clinic Criteria , 2014, Circulation. Cardiovascular imaging.

[54]  K. Sliwa,et al.  HIV and the heart: the impact of antiretroviral therapy: a global perspective. , 2013, European heart journal.

[55]  J. Tardif,et al.  Management of pericarditis and myocarditis: could heart-rate-reducing drugs hold a promise? , 2013, Archives of cardiovascular diseases.

[56]  M. Karck,et al.  Constrictive pericarditis: risks, aetiologies and outcomes after total pericardiectomy: 24 years of experience. , 2013, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[57]  E. Fabris,et al.  Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis. , 2013, The American journal of cardiology.

[58]  Y. Adler,et al.  A randomized trial of colchicine for acute pericarditis. , 2013, The New England journal of medicine.

[59]  B. Hoit,et al.  Post-cardiac injury syndromes. An emerging cause of pericardial diseases. , 2013, International journal of cardiology.

[60]  Richard D. White,et al.  American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. , 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[61]  I. Touitou,et al.  The phenotype of TNF receptor-associated autoinflammatory syndrome (TRAPS) at presentation: a series of 158 cases from the Eurofever/EUROTRAPS international registry , 2013, Annals of the rheumatic diseases.

[62]  G. Ligabue,et al.  Good Prognosis for Pericarditis With and Without Myocardial Involvement: Results From a Multicenter, Prospective Cohort Study , 2013, Circulation.

[63]  R. Nishimura,et al.  Mechanism of septal bounce in constrictive pericarditis: a simultaneous cardiac catheterisation and echocardiographic study , 2013, Heart.

[64]  Y. Jang,et al.  The incidence and clinical outcome of constrictive physiology after coronary artery bypass graft surgery. , 2013, Journal of the American College of Cardiology.

[65]  S. Flamm,et al.  Biventricular Mechanics in Constrictive Pericarditis Comparison With Restrictive Cardiomyopathy and Impact of Pericardiectomy , 2013, Circulation. Cardiovascular imaging.

[66]  J. Oh,et al.  Echocardiography in pericardial diseases: new developments , 2013, Heart Failure Reviews.

[67]  J. Oh,et al.  Effusive-constrictive pericarditis , 2013, Heart Failure Reviews.

[68]  A. Ristic,et al.  Pericardioscopy and epi- and pericardial biopsy—a new window to the heart improving etiological diagnoses and permitting targeted intrapericardial therapy , 2013, Heart Failure Reviews.

[69]  H. Schaff,et al.  Pericardiectomy vs medical management in patients with relapsing pericarditis. , 2012, Mayo Clinic proceedings.

[70]  W. Edwards,et al.  MR imaging findings in 76 consecutive surgically proven cases of pericardial disease with CT and pathologic correlation , 2012, The International Journal of Cardiovascular Imaging.

[71]  H. Schaff,et al.  Completion pericardiectomy for recurrent constrictive pericarditis: importance of timing of recurrence on late clinical outcome of operation. , 2012, The Annals of thoracic surgery.

[72]  Y. Adler,et al.  Efficacy and safety of colchicine for pericarditis prevention. Systematic review and meta-analysis , 2012, Heart.

[73]  Jeroen J. Bax,et al.  2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). , 2011, European heart journal.

[74]  D. Choi,et al.  Effects of simvastatin on the pharmacokinetics of diltiazem and its main metabolite, desacetyldiltiazem, after oral and intravenous administration in rats: possible role of P-glycoprotein and CYP3A4 inhibition by simvastatin , 2011, Pharmacological reports : PR.

[75]  S. Flamm,et al.  Pericardial delayed hyperenhancement with CMR imaging in patients with constrictive pericarditis undergoing surgical pericardiectomy: a case series with histopathological correlation. , 2011, JACC. Cardiovascular imaging.

[76]  Matthew W. Martinez,et al.  Cardiac Magnetic Resonance Imaging Pericardial Late Gadolinium Enhancement and Elevated Inflammatory Markers Can Predict the Reversibility of Constrictive Pericarditis After Antiinflammatory Medical Therapy: A Pilot Study , 2011, Circulation.

[77]  Y. Adler,et al.  Contemporary features, risk factors, and prognosis of the post-pericardiotomy syndrome. , 2011, The American journal of cardiology.

[78]  Y. Adler,et al.  Colchicine for Recurrent Pericarditis (CORP) , 2011, Annals of Internal Medicine.

[79]  D. Adam,et al.  Speckle Tracking Imaging in Acute Inflammatory Pericardial Diseases , 2011, Echocardiography.

[80]  F. Cinetto,et al.  Azathioprine in isolated recurrent pericarditis: a single centre experience. , 2011, International journal of cardiology.

[81]  A. Brucato,et al.  Prevalence of C-Reactive Protein Elevation and Time Course of Normalization in Acute Pericarditis: Implications for the Diagnosis, Therapy, and Prognosis of Pericarditis , 2011, Circulation.

[82]  S. Yusuf,et al.  Radiation-Induced Heart Disease: A Clinical Update , 2011, Cardiology research and practice.

[83]  E. Belley‐Cote,et al.  Acute and recurring pericarditis: More colchicine, less corticosteroids. , 2010, World journal of cardiology.

[84]  Y. Adler,et al.  Triage and management of pericardial effusion , 2010, Journal of cardiovascular medicine.

[85]  G. Biondi-Zoccai,et al.  International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. , 2010, American heart journal.

[86]  M. Desai,et al.  The Role of Multimodality Imaging in the Management of Pericardial Disease , 2010, Circulation. Cardiovascular imaging.

[87]  J. Oh,et al.  Infectious pericarditis: an experience spanning a decade , 2009, Acta cardiologica.

[88]  Y. Adler,et al.  Aetiological diagnosis in acute and recurrent pericarditis: when and how , 2009, Journal of cardiovascular medicine.

[89]  G. Brambilla,et al.  Corticosteroids for Recurrent Pericarditis: High Versus Low Doses: A Nonrandomized Observation , 2008, Circulation.

[90]  B. Mayosi.  Contemporary trends in the epidemiology and management of cardiomyopathy and pericarditis in sub-Saharan Africa , 2007, Heart.

[91]  R. Shabetai,et al.  Pathogenesis, management, and prevention of recurrent pericarditis , 2007, Journal of cardiovascular medicine.

[92]  L. Coda,et al.  Indicators of Poor Prognosis of Acute Pericarditis , 2007, Circulation.

[93]  J. Seward,et al.  Apex-to-base dispersion in regional timing of left ventricular shortening and lengthening. , 2006, Journal of the American College of Cardiology.

[94]  B. Mayosi,et al.  Tuberculous Pericarditis , 2005, Circulation.

[95]  M. Imazio,et al.  Colchicine in Addition to Conventional Therapy for Acute Pericarditis: Results of the COlchicine for acute PEricarditis (COPE) Trial , 2005, Circulation.

[96]  M. Imazio,et al.  Colchicine as first-choice therapy for recurrent pericarditis: results of the CORE (COlchicine for REcurrent pericarditis) trial. , 2005, Archives of internal medicine.

[97]  Richard A. Lange,et al.  Clinical practice. Acute pericarditis. , 2004, The New England journal of medicine.

[98]  D. Girling,et al.  Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. , 2004, QJM : monthly journal of the Association of Physicians.

[99]  M. Lauer,et al.  Constrictive pericarditis: etiology and cause-specific survival after pericardiectomy. , 2004, Journal of the American College of Cardiology.

[100]  M. Imazio,et al.  Day-hospital treatment of acute pericarditis: a management program for outpatient therapy. , 2004, Journal of the American College of Cardiology.

[101]  G. Permanyer-Miralda.  Acute pericardial disease: approach to the aetiologic diagnosis , 2004, Heart.

[102]  D. Faxon,et al.  ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography--summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echoca , 2003, Journal of the American College of Cardiology.

[103]  D. H. Spodick,et al.  Acute cardiac tamponade. , 2003, The New England journal of medicine.

[104]  J. Soler‐Soler,et al.  Clinical clues to the causes of large pericardial effusions. , 2000, The American journal of medicine.

[105]  S. Hernández-Díaz,et al.  Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal tract bleeding/perforation: an overview of epidemiologic studies published in the 1990s. , 2000, Archives of internal medicine.

[106]  P. Touboul,et al.  Serum cardiac troponin I and ST-segment elevation in patients with acute pericarditis. , 2000, European heart journal.

[107]  J. Seward,et al.  Calcific Constrictive Pericarditis: Is It Still with Us? , 2000, Annals of Internal Medicine.

[108]  A. Evangelista,et al.  Correlation between clinical and Doppler echocardiographic findings in patients with moderate and large pericardial effusion: implications for the diagnosis of cardiac tamponade. , 1999, American heart journal.

[109]  J. Seward,et al.  Constrictive pericarditis in the modern era: evolving clinical spectrum and impact on outcome after pericardiectomy. , 1999, Circulation.

[110]  A. Whelton.  Nephrotoxicity of nonsteroidal anti-inflammatory drugs: physiologic foundations and clinical implications. , 1999, The American journal of medicine.

[111]  B. Pedersen,et al.  Exercise and Immune Function , 1999, Sports medicine.

[112]  J. Soler‐Soler,et al.  Should pericardial drainage be performed routinely in patients who have a large pericardial effusion without tamponade? , 1998, The American journal of medicine.

[113]  W. Edwards,et al.  Pathology of radiation-induced heart disease: a surgical and autopsy study of 27 cases. , 1996, Human pathology.

[114]  R. Swanton,et al.  How do the clinical findings in patients with pericardial effusions influence the success of aspiration? , 1995, British heart journal.

[115]  B. Hoit,et al.  The Paradoxical Pulse in Tamponade: Mechanisms and Echocardiography Correlates , 1994, Echocardiography.

[116]  J. Soler‐Soler,et al.  Purulent pericarditis: review of a 20-year experience in a general hospital. , 1993, Journal of the American College of Cardiology.

[117]  R. Siegel,et al.  Rapid resolution of symptomatic acute pericarditis with ketorolac tromethamine: a parenteral nonsteroidal antiinflammatory agent. , 1993, American heart journal.

[118]  D. Felson,et al.  A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. , 1993, Archives of internal medicine.

[119]  S. Rezkalla,et al.  Enhancement of coxsackievirus B4 virulence by indomethacin. , 1990, The Journal of laboratory and clinical medicine.

[120]  E. W. Hancock,et al.  The etiologic spectrum of constrictive pericarditis. , 1987, American heart journal.

[121]  J. A. Robinson,et al.  A nonsteroid anti-inflammatory drug exacerbates Coxsackie B3 murine myocarditis. , 1985, Journal of the American College of Cardiology.

[122]  J. Doppman,et al.  Constrictive pericardial disease: prognostic significance of a nonvisualized left ventricular wall. , 1985, Radiology.

[123]  R. Rubin,et al.  Clinical, microbiologic and therapeutic aspects of purulent pericarditis. , 1975, The American journal of medicine.

[124]  D. Spodick.  Electrocardiogram in acute pericarditis. Distributions of morphologic and axial changes by stages. , 1974, The American journal of cardiology.

[125]  C. Wilson,et al.  The induction of gross myocardial lesions by a Coxsackie (pleurodynia) virus and cortisone. , 1956, The Journal of clinical investigation.

[126]  C. Asher,et al.  Pericarditis , 1830, The Medico-chirurgical review.

[127]  L. Buckley,et al.  Interleukin-1 blockade for the treatment of pericarditis , 2018, European heart journal. Cardiovascular pharmacotherapy.

[128]  S. Seth,et al.  NT pro B type natriuretic peptide levels in constrictive pericarditis and restrictive cardiomyopathy. , 2015, Indian heart journal.

[129]  A. Clark,et al.  Fluid Management in Patients with Chronic Heart Failure , 2015 .

[130]  M. Link,et al.  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Associat , 2015, Journal of the American College of Cardiology.

[131]  P. Rautava,et al.  [Clinical profile and influences on outcomes in patients hospitalized for acute pericarditis]. , 2014, Duodecim; laaketieteellinen aikakauskirja.

[132]  J. Stockman.  Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort , 2011 .

[133]  D. Spodick,et al.  Contemporary Reviews in Cardiovascular Medicine Controversial Issues in the Management of Pericardial Diseases , 2010 .

[134]  J. Seward,et al.  Disparate patterns of left ventricular mechanics differentiate constrictive pericarditis from restrictive cardiomyopathy. , 2008, JACC. Cardiovascular imaging.

[135]  M. Yacoub,et al.  Guidelines on the Diagnosis and Management of Pericardial Diseases , 2004 .

[136]  Pamela S Douglas,et al.  Acc/aha/ase 2003 Guideline Update for the Clinical Application of Echocardiography: Summary Article a Report of the American College of Cardiology/american Heart Association Task Force on Practice Guidelines (acc/aha/ase Committee to Update the 1997 Guidelines for the Clinical Application of Echocar , 2003 .

[137]  D. Spodick,et al.  The normal and diseased pericardium: current concepts of pericardial physiology, diagnosis and treatment. , 1983, Journal of the American College of Cardiology.

[138]  See Clinical Perspective , 2022 .